Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma-Reference-Cited by-同舟云学术

Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma

Published:2018-09 Issue: Volume:431 Page:182-189
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Hagiwara Nobuhisa,Watanabe Motoki,Iizuka-Ohashi Mahiro,Yokota Isao,Toriyama Seijiro,Sukeno Mamiko,Tomosugi Mitsuhiro,Sowa Yoshihiro,Hongo Fumiya,Mikami Kazuya,Soh Jintetsu,Fujito Akira,Miyashita Hiroaki,Morioka Yukako,Miki Tsuneharu,Ukimura Osamu,Sakai Toshiyuki

Funder

Grant-in-Aid for Scientific Research on Innovative Areas

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Renal-cell carcinoma;Cohen;N. Engl. J. Med.,2005

2. Cancer statistics, 2008;Jemal;Ca - Cancer J. Clin.,2008

3. The global burden of cancer 2013;Fitzmaurice;JAMA Oncol.,2015

4. Role of VHL gene mutation in human cancer;Kim;J. Clin. Oncol.,2004

5. Integrated molecular analysis of clear-cell renal cell carcinoma;Sato;Nat. Genet.,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Lipid metabolism reprogramming in renal cell carcinomas;Medical Oncology;2024-09-06

3. Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways;Frontiers in Cell and Developmental Biology;2024-06-12

4. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics;Journal of Hematology & Oncology;2023-09-12

5. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery;Expert Review of Molecular Diagnostics;2023-03-28